Juliana Calheiros

Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas

H. Sousa, D. Kolarich, C. Reis, 2019, Theranostics.

BBIT20 inhibits homologous DNA repair with disruption of the BRCA1–BARD1 interaction in breast and ovarian cancer

Maria-José U. Ferreira, J. L. Costa, P. Glazer, 2021, British journal of pharmacology.

Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target

L. Saraíva, Juliana Calheiros, L. Raimundo, 2021, Cancers.

Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance

Maria M. M. Santos, J. L. Costa, L. Saraíva, 2021, Cancers.

BRCA1/P53: Two strengths in cancer chemoprevention.

Helena Ramos, L. Saraíva, J. Loureiro, 2020, Biochimica et biophysica acta. Reviews on cancer.

SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner

Maria M. M. Santos, Helena Ramos, L. Saraíva, 2020, International journal of molecular sciences.

A selective p53 activator and anticancer agent to improve colorectal cancer therapy.

A. Inga, Helena Ramos, L. Saraíva, 2021, Cell reports.

Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53.

V. Corbo, L. Saraíva, Juliana Calheiros, 2023, Biochimica et biophysica acta. Reviews on cancer.

Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair

L. Saraíva, S. Minuzzo, Juliana Calheiros, 2023, Cancers.